2013 Apr 15 Annual Report 2012 - Phosphagenics

More documents

Recommendations

Info

116 PHOSPHAGENICS ANNUAL REPORT 2012
corporate directory Phosphagenics Limited (ABN 32 056 482 403) BOARD OF DIRECTORS Mr Jonathan Addison (Chairman and Independent Director) Mr Harry Rosen (Founder and President) Dr Esra Ogru (Chief Executive Officer) Mr Don Clarke (Independent Director) Mr Stuart James (Independent Director) Dr Sandra Webb (Independent Director) COMPANY SECRETARY Mr Mourice Garbutt CHIEF FINANCIAL OFFICER Mr Ashley Arnott INVESTOR RELATIONS Mr David Segal REGISTERED OFFICE 11 Duerdin Street Clayton VIC 3168 Australia PRINCIPAL BUSINESS OFFICE 11 Duerdin Street Clayton VIC 3168 Australia PO Box 1415 Clayton South MDC VIC 3169 SHARE REGISTER Computershare Investor Services Pty Ltd, Yarra Falls, 452 Johnston Street Abbotsford VIC 3067 Australia AUDITORS Ernst & Young 8 Exhibition Street Melbourne VIC 3000 Australia AUSTRALIAN SECURITIES EXCHANGE LIMITED The company’s securities are quoted on the official lists of the Australian Securities Exchange Limited (ASX). The company’s ASX Code is POH and the home exchange is in Melbourne. AMERICAN DEPOSITORY RECEIPT In July 2007, the company upgraded its level 1 American Depository Receipt (ADR) on the US over-the-counter (OTC) securities market to the international OTCQX, a new premium market tier in the US for international exchange-listed companies, operated by OTC Markets Group, Inc. The company’s ADR ticker symbol is PPGNY. Telephone: (03) 9565 1119 Facsimile: (03) 9565 1151 Email: info@phosphagenics.com
Page 1 and 2:
20 12 Annual Report PHOSPHAGENICS P
Page 3 and 4:
highlights March... April... May...
Page 5 and 6:
03 Jonathan Addison Chairman & Inde
Page 7 and 8:
COLLABORATIONS Strategic Collaborat
Page 9 and 10:
The Phosphagenics Evolution THE STO
Page 11 and 12:
“ We also reached agreement with
Page 13 and 14:
Overview of our opioid development
Page 15 and 16:
13 is branded as Butrans or Norspan
Page 17 and 18:
Personal Care ASHLAND INC (FORMERLY
Page 19 and 20:
BEAUTY IS MORE THAN SKIN DEEP 17 EL
Page 21 and 22:
cellulite contour crème BioElixia
Page 23 and 24:
Intellectual Property Title Countri
Page 25 and 26:
2009 2008 2007 2006 6.8 7.8 22.2 23
Page 27 and 28:
DR ESRA OGRU (AGED 37 YEARS) BSC (H
Page 29 and 30:
Senior Management DR PAUL GAVIN Chi
Page 31 and 32:
Phosphagenics Limited ABN 32 056 48
Page 33 and 34:
Directors’ Report Your directors
Page 35 and 36:
Directors’ Report continued Looki
Page 37 and 38:
Directors’ Report continued Commi
Page 39 and 40:
Directors’ Report continued REMUN
Page 41 and 42:
Page 43 and 44:
Directors’ Report continued Share
Page 45 and 46:
Directors’ Report continued Share
Page 47 and 48:
Exercise Price Expiry Date Net othe
Page 49 and 50:
Exercise Price Expiry Date Net othe
Page 51 and 52:
Fair value per performance right at
Page 53 and 54:
Page 55 and 56:
Auditors Independence Declaration 5
Page 57 and 58:
Corporate Governance Statement cont
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68: Consolidated statement of fi nancia
Page 69 and 70: Consolidated statement of changes i
Page 71 and 72: Notes to the consolidated fi nancia
Page 73 and 74: Application date of standard Impact
Page 113 and 114: Independent Auditor’s Report 111
Page 115 and 116: Additional Shareholder Information
Page 117: Additional Shareholder Information
show all

2013 Apr 15 Annual Report 2012 - Phosphagenics

Create successful ePaper yourself

Delete template?

Save as template?